Search for: "Roche Holdings, Inc." Results 181 - 200 of 253
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Aug 2009, 6:48 am
Prosecutors contend that companies that were deceived include Potash Corp of Saskatchewan Inc, Roche Holding AG and STMicroelectronics NV. [read post]
13 Aug 2009, 12:10 pm
"); Hoffman-La Roche Inc. v. [read post]
30 Jul 2009, 8:45 pm
Hoffmann-La Roche, Inc., 541 F.3d 1115, 1129 (Fed. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
8 Jul 2009, 4:20 pm
High Liner Foods, Inc., No. 06-11644-RWZ, slip op. at 17 (D. [read post]
11 Jun 2009, 3:36 pm
In an unpublished opinion, the Eleventh Circuit affirmed a trial court’s grant of summary judgment in a case in which the mother of a 17 year-old who committed suicide in 2000 sued Hoffman-La Roche, Inc. [read post]
11 Jun 2009, 7:37 am
 The opinion is sweeping, and appears to extend the holding in Boeing North American, Inc. [read post]
11 Jun 2009, 2:00 am
Hoffman-La Roche, Inc., No. 07-15980, slip op. (11th Cir. [read post]
30 Apr 2009, 8:24 am
Roche Holding AG(RHHBY) unit is recalling Accu-Chek Spirit insulin pumps that were sent to the U.S., the Food and Drug Administration said Thursday noted in a recall notice posted on its Web site.The Roche unit, Disetronic Medical Systems Inc., said the "up" and "down" buttons can malfunction on some pumps. [read post]
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition against… [read post]
9 Apr 2009, 2:16 pm
A subsidiary Swiss drug maker of Roche Holding AG has announced a phased market withdraw of the injectable, psoriasis treatment drug, Raptiva because of Raptiva's link to a deadly brain disease. [read post]
9 Apr 2009, 12:34 pm
Due To Link With Fatal Brain Infection, Progressive Multifocal Leukoencephalopathy (PML) (Posted by Tom Lamb at DrugInjuryWatch.com) On April 8, 2009 Genentech Inc. -- which was just acquired by Roche Holding AG in March 2009 -- issued a press release announcing "a phased voluntary withdrawal of psoriasis drug Raptiva ® (efalizumab) from the U.S. market"  due to its link to a brain infection, progressive multifocal leukoencephalopathy… [read post]
6 Apr 2009, 8:20 am
., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
17 Mar 2009, 3:28 am
Hoffman-La Roche, Inc., And Roche Laboratories, Inc., 2009 WL 614484 (N.J.Super.A.D.) [read post]